The U.S. Medicare program's decision to tightly limit coverage for the first drug meant to slow the course of Alzheimer's disease has raised the stakes for companies trying to make the next one.
Apr 11, 2022
0
2
Drug maker Roche Holding AG says its first-half profit was weighed down by the surging Swiss franc and one-time effects, while solid sales of cancer treatments helped push revenue higher.
Jul 23, 2015
0
9
(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.
Oct 16, 2014
0
0
Growing demand for its cancer medicines and diagnostic tests used by clinical laboratories helped Swiss drug maker Roche Holding AG post a modest 2.4 percent increase in full-year profits.
Jan 30, 2013
0
0
